Patton Unveils Second-Generation, US-Made, Commercial-Grade, FIPS-140 Ultra-Secure SIP Phone with Enhanced NG911 Compliance
Patton... Let's Connect! GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- Patton—world leader…
Databricks Unveils Lakeflow Designer for Data Analysts to Build Reliable Pipelines Without Coding
New Lakeflow Designer offers drag-and-drop interface to generate production pipelines; Lakeflownow Generally…
PeterMD Announces Official Website Update Featuring Telemedicine Services for Men’s Hormone Health and TRT Support
VERO BEACH, June 10, 2025 (GLOBE NEWSWIRE) -- PeterMD, a Florida-based men's…
Discover the Superhero Within: New Book ‘Stories with Purpose’ by Laura G. Patac Helps Readers Turn Life’s Challenges into Purpose
What if your favorite superhero story was already unfolding, in your own…
DC Studios Teams Up With Amazon to Give Prime Members Early Access to the Summers Most-Anticipated Big-Screen Event: Superman
Amazon Prime Members Can Soar Above the Crowd—and, Like Superman Himself, Do…
Sandisk Announces Participation in Investor Conference
MILPITAS, Calif.--(BUSINESS WIRE)--Sandisk Corporation (NASDAQ: SNDK) announced today that management will participate…
Enovis to Participate in Upcoming Investor Conferences
June 06, 2025 16:05 ET Â | Source: Enovis Corporation Wilmington, DE, June…
Deckers Brands to Present at Upcoming Conferences
GOLETA, Calif.--(BUSINESS WIRE)--Deckers Brands (NYSE:DECK), a global leader in designing, marketing and…
KKR to Present at the Morgan Stanley US Financials Conference 2025
NEW YORK--(BUSINESS WIRE)--KKR & Co. Inc. (NYSE: KKR) announced today that Adam…
![Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]](https://i0.wp.com/ml-eu.globenewswire.com/media/NjEzMmQ4NzAtZTBkMS00ZDhhLTkyYjgtOGM3YzY1ZWM5M2U5LTEwMTQyODItMjAyNS0wNi0wMi1lbg==/tiny/Sandoz-International-GmbH.png?w=420&resize=420,280&ssl=1 "Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]")
Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA…